ARTICLE | Clinical News
DiabeCell: Phase I/IIa started
July 27, 2009 7:00 AM UTC
Living Cell Technologies began an open-label, dose-escalation, New Zealand Phase I/IIa trial to evaluate DiabeCell implant in 8 patients with poorly controlled diabetes. ...